Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A new study explores the "drusen ooze" hypothesis, revealing how drusen can regress without atrophy in age-related macular ...

OpZira Inc was formed after Alcon acquired LumiThera, with LumiThera's diagnostic products spun off to create the new company ...

Alcon has announced its launch of the first fully personalized LASIK treatment, wavelight plus, in the US and Canada. 1 The ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they had the ability to cure one eye disease or condition in the snap of their ...

Timothy Lai, MD, shares promising one-year results from the SALWEEN study on faricimab for polypoidal choroidal vasculopathy ...

In both trials, Beacon’s lead program, laru-zova, was found to be well-tolerated by SKYLINE participants through month 36 and ...

The presence of AMD predicted an increased risk of all-cause and CVD mortality in patients with a high risk of CVD, even in ...

A panelist discusses how the iDose implant is surgically placed into the scleral wall with precision, can be repositioned if needed, and remains stable even after procedures like goniotomy, making it ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A panelist discusses how interventional glaucoma emphasizes early, proactive treatment strategies to reduce IOP and medication burden while addressing patient adherence and long-term disease control.